Harnessing mRNA-encoded Cytokines as Immune Therapeutics for a Focused Immune Response
Time: 4:30 pm
day: Conference Day One
Details:
- Engineered cytokines encoded by nucleoside modified mRNA and delivered in LNPs enables tailored and focused immune therapeutics
- Multiplexing a myriad of cytokines by the mRNA/LNP platform allows next-generation broad immunomodulation for clinical benefit
- Providing examples of harnessing mRNA technology for manipulating the immune response via cytokines for autoimmune and inflammatory disease
